https://www.selleckchem.com/products/ten-010.html
85 (95% CI 0.67, 1.08), 0.80 (95% CI 0.49, 1.3, and 0.87 (95% CI 0.34, 2.2 respectively. The negative outcome control analysis did not suggest unobserved confounding. Current prescription of metformin was not associated with the risk of COVID-19 or COVID-19-related mortality. It is safe to continue prescribing metformin to improve glycemic control in patients with. Current prescription of metformin was not associated with the risk of COVID-19 or COVID-19-related mortality. It is safe to continue prescribing metformin to improve glyc
Suka
Komentar
Membagikan
